PREVENTION OF TRANSMISSION OF HEPATITIS C VIRUS IN BONE MARROW TRANSPLANTATION BY TREATING THE DONOR WITH??-INTERFERON1
Authors:
- Robert J. SoifferRSRobert J. Soiffer
- George B. McDonaldGMGeorge B. McDonald
- David MyersonDMDavid Myerson
- Joyce FingerothJFJoyce Fingeroth
- Jerome RitzJRJerome Ritz
- 1 November 1996
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (9) , 1358-1360
Abstract
Transmission of hepatitis C virus (HCV) in the setting of allogeneic bone marrow transplantation can occur through an infected marrow donor. Prevention of transmission may reduce the risks of peritransplant complications. We describe a 43-year-old patient with chronic myelogenous leukemia whose HLA-identical donor was found to be HCV antibody positive and HCV RNA positive by polymerase chain reaction (PCR). The patient was HCV antibody negative and HCV RNA negative by PCR of the serum. For 6 months before bone marrow transplantation, the donor was treated with alpha-interferon at a standard dose. After 3 months, HCV RNA was no longer detectable by PCR. Interferon was discontinued 1 week before harvest. Bone marrow cellularity was normal. Engraftment was prompt. The recipient's serum remained negative for HCV RNA at 1, 3, 5, and 10 months after transplantation. Hepatitis C transmission from a viremic donor to an HCV-seronegative recipient may be preventable by treating the donor with alpha-interferon.Keywords
This publication has 8 references indexed in Scilit:
- Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Blood, 1995
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical courseBlood, 1994
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Infection of peripheral mononuclear blood cells by hepatitis C virusJournal of Hepatology, 1992
- Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipientsNephrology Dialysis Transplantation, 1992
- Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-αHepatology, 1992
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990